Simulations Plus Announces Second Quarter Fiscal Year 2025 Earnings and Conference Call DateBusiness Wire • 03/20/25
Simulations Plus to Present at the KeyBanc Capital Markets Virtual Healthcare Investor ForumBusiness Wire • 03/10/25
Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus® EnhancementsBusiness Wire • 01/22/25
Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024Business Wire • 01/14/25
Simulations Plus Announces First Quarter Fiscal Year 2025 Earnings and Conference Call DateBusiness Wire • 12/17/24
Wall Street Analysts Predict a 56.99% Upside in Simulations Plus (SLP): Here's What You Should KnowZacks Investment Research • 11/26/24
Simulations Plus (SLP) Stock Jumps 8.9%: Will It Continue to Soar?Zacks Investment Research • 11/22/24
Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting InjectablesBusiness Wire • 11/13/24
How Much Upside is Left in Simulations Plus (SLP)? Wall Street Analysts Think 77.52%Zacks Investment Research • 11/08/24